[1]
Dolapsakis, C. et al. 2025. Unmasking of normocalcemic primary hyperparathyroidism after sodium-glucose cotransporter-2 inhibitor initiation. European Journal of Case Reports in Internal Medicine. 12, 2 (Jan. 2025). DOI:https://doi.org/10.12890/2025_005169.